The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas

International Journal of Cancer

Volumn 134, Issue 6, 2014, Pages 1323-1334

  Quabius, Elgar Susanne ^a   Möller, Paul ^a   Haag, Jochen ^a   Pfannenschmidt, Saskia ^a   Hedderich, Jürgen ^a   Görögh, Tibor ^a   Röcken, Christoph ^a   Hoffmann, Markus ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

HNSCC; HPV; SLPI; smoking

Indexed keywords

AROMATIC HYDROCARBON; LIPOCORTIN 2; NICOTINIC RECEPTOR; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HYPOPHARYNX; IMMUNOHISTOCHEMISTRY; LARYNX; MALE; MUCOSA; OROPHARYNX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; TOBACCO DEPENDENCE; VERY ELDERLY; VIRUS DETECTION; WART VIRUS;

EID: 84891828243     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28462     Document Type: Article

References (36)

1. Miller DL, Puricelli MD, Stack MS,. Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma. Biochem J 2012; 443: 339-53.
2. Marty R, Roze S, Bresse X, et al. Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe. BMC Cancer 2013; 8: 13:10.
3. Báez A,. Genetic and environmental factors in head and neck cancer genesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2008; 26: 174-200.
4. Hoffmann M, Kahn T, Mahnke CG, et al. Prevalence of human papillomavirus in squamous cell carcinoma of the head and neck determined by polymerase chain reaction and Southern blot hybridization: proposal for optimized diagnostic requirements. Acta Otolaryngol 1998; 118: 138-44.
5. Hoffmann M, Ihloff AS, Görögh T, et al. p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer. Int J Cancer 2010; 127: 1595-602.
6. Hoffmann M, Tribius S, Quabius ES, et al. HPV DNA, E6 I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer-how valid is p16INK4A as surrogate marker? Cancer Lett 2012; 323: 88-96.
7. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344: 1125-31.
8. Gillison ML,. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004; 31: 744-54.
9. O'Rorke MA, Ellison MV, Murray LJ, et al. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol 2012; 48: 1191-20.
10. Akervall J,. Gene profiling in squamous cell carcinoma of the head and neck. Cancer Metastasis Rev 2005; 24: 87-94.
11. Lowy DR, Munger K,. Prognostic implications of HPV in oropharyngeal cancer. N Engl J Med 2010; 363: 82-4.
12. Tribius S, Ihloff AS, Rieckmann T, et al. Impact of HPV status on treatment of squamous cell cancer of the oropharynx: what we know and what we need to know. Cancer Lett 2011; 304: 71-9.
13. Hoffmann M, Görögh T, Gottschlich S, et al. Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Cancer Lett 2005; 218: 199-206.
14. Cordes C, Häsler R, Werner C, et al. The level of secretory leukocyte protease inhibitor is decreased in metastatic head and neck squamous cell carcinoma. Int J Oncol 2011; 39: 185-91.
15. Hoffmann M, Quabius ES, Tribius S, et al. Human papillomavirus infection in head and neck cancer-the role of the secretory leukocyte protease inhibitor. Oncol Rep 2013; 29: 1962-8.
16. Woodham AW, Da Silva DM, Skeate JG, et al. The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection. PLoS One 2012; 7: e43519.
17. Shi D, Guo W, Chen W, et al. Nicotine promotes proliferation of human nasopharyngeal carcinoma cells by regulating α7AChR, ERK, HIF-1α and VEGF/PEDF signaling. PLoS One 2012; 7: e43898.
18. Oyama T, Sugio K, Uramoto H, et al. Increased cytochrome P450 and aryl hydrocarbon receptor in bronchial epithelium of heavy smokers with non-small cell lung carcinoma carries a poor prognosis. Front Biosci 2007; 12: 4497-503.
19. Remmerbach TW, Brinckmann UG, Hemprich A, et al. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J Clin Virol 2004; 30: 302-8.
20. Quabius ES, Ossenkop L, Harder S, et al. Dental implants stimulate expression of interleukin-8 and its receptor in human blood-an in vitro approach. J Biomed Mater Res B: Appl Biomater 2012; 100: 1283-8.
21. Kuchipudi SV, Tellabati M, Nelli RK, et al. 18S rRNA is a reliable normalisation gene for real time PCR based on influenza virus infected cells. Virol J 2012; 9: 230.
22. Pfaffl MW,. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 9: 2002-7.
23. Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-75.
24. Wu LZ, Duan DM, Liu YF, et al. Nicotine favors osteoclastogenesis in human periodontal ligament cells co-cultured with CD4(+) T cells by upregulating IL-1β. Int J Mol Med 2013; 4: 938-42.
25. Wen J, Nikitakis NG, Chaisuparat R, et al. Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma. Am J Pathol 2011; 178: 2866-78.
26. Dasgupta S, Tripathi PK, Qin H, et al. Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma. Oral Oncol 2006; 42: 306-16.
27. Wahl SM, McNeely TB, Janoff EN, et al. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I. Oral Dis 1997; 3 (Suppl 1): S64-9.
28. Ma G, Greenwell-Wild T, Lei K, et al. Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J Exp Med 2004; 200: 1337-46.
29. Chen Z, Malhotra PS, Thomas GR, et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 1999; 5: 1369-79.
30. Braakhuis B, Graveland A, Dijk F, et al. Expression signature in peripheral blood cells for molecular diagnosis of head and neck squamous cell carcinoma. Oral Dis 2012. doi: 10.11.
31. Chang J, Burkett PR, Borges CM, et al. MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling. Proc Natl Acad Sci USA 2013; 110: 2270-5.
32. Sallenave JM, Shulmann J, Crossley J, et al. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am J Respir Cell Mol Biol 1994; 11: 733-41.
33. Gonçalves RB, Coletta RD, Silvério KG, et al. Impact of smoking on inflammation: overview of molecular mechanisms. Inflamm Res 2011; 60: 409-24.
34. Rom O, Avezov K, Aizenbud D, et al. Cigarette smoking and inflammation revisited. Respir Physiol Neurobiol 2013; 187: 5-10.
35. Drannik AG, Henrick BM, Rosenthal KL,. War and peace between WAP and HIV: role of SLPI, trappin-2, elafin and ps20 in susceptibility to HIV infection. Biochem Soc Trans 2011; 39: 1427-32.
36. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.